Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1148020130380010020
Á¶¼±´ëÇб³ÀÇ´ë³í¹®Áý
2013 Volume.38 No. 1 p.20 ~ p.22
De novo Acute Myeloid Leukemia with JAK2 V617F: A Case Report
Kim Woo-Sung

Park Gyun-Cheol
Kang Sung-Ho
Park Chi-Young
Jang Sook-Jin
Moon Dae-Soo
Park Geon
Abstract
JAK2 V617F mutation is a common event in chronic myeloproliferative disorders. However, de novo acute myeloid leukemiawith JAK2 V617F is rarely encountered. The authors report the case of a 74-year-old male with de novo acute myeloblasticleukemia without maturation (AML M1) and a JAk2 V617F heterozygotic mutation. Despite treatment with standardAML regimens, the patient died 2 months after a diagnosis of acute leukemia. This case of an AML patient with a JAK2V617F mutation with a poor prognosis suggests that despite its rarity, a JAK2 V617F mutational study be considered forprognostic purposes in AML.
KEYWORD
AML, M1, JAK2, V617F
FullTexts / Linksout information
Listed journal information